Division of Digestive and Liver Diseases, Department of Medicine, Columbia University Medical Center, New York, New York.
Department of Obstetrics and Gynecology, Columbia University Medical Center, New York, New York.
Clin Gastroenterol Hepatol. 2020 May;18(5):1133-1141.e3. doi: 10.1016/j.cgh.2019.07.028. Epub 2019 Jul 20.
BACKGROUND & AIMS: Patients with inflammatory bowel diseases (IBDs) have a high risk of venous thromboembolism (VTE). We assessed the timing and risk factors associated with readmission to the hospital for VTE among patients with IBD.
We collected data from the Nationwide Readmissions Database on IBD index admissions resulting in readmission to the hospital for VTE within 60 days, from 2010 through 2014. We used univariable and multivariable regression to assess risk factors associated with VTE readmission with unadjusted risk ratio (RR) and adjusted RR (aRR) as measures of effect. Time to VTE readmission was assessed in 10-day intervals, for up to 90 days.
We identified 872,122 index admissions of patients with IBD; 1160 resulted in readmission with VTE. More than 90% of readmissions occurred within 60 days of discharge from the index admission. Factors associated with hospital readmission with VTE included prior VTE, longer length of hospital stay, comorbidities, having a flexible sigmoidoscopy or colonoscopy at index admission, and age older than 18 years. Additional risk factors included Clostridium difficile infection at index admission (aRR, 1.47; 95% CI, 1.17-1.85) and discharge to a skilled nursing facility or intermediate care facility (aRR, 1.39; 95% CI, 1.14-1.70) or discharge with home health services (aRR, 1.65; 95% CI, 1.41-1.94).
Among patients admitted to the hospital with IBD, most readmissions with VTE occur within 60 days of discharge. Readmission with VTE is associated with C difficile infection and discharge to a skilled nursing facility, intermediate care facility, or with home health services. Studies are needed to evaluate the potential benefit of extending VTE prophylaxis for patients admitted to the hospital with IBD for up to 2 months after discharge, to minimize risk.
炎症性肠病(IBD)患者有发生静脉血栓栓塞症(VTE)的高风险。本研究评估了 IBD 患者发生 VTE 再住院的时间和相关危险因素。
我们从 2010 年至 2014 年的全国再入院数据库中收集了 IBD 索引入院患者的数据,这些患者因 VTE 再住院,时间在索引入院后 60 天内。我们使用单变量和多变量回归评估了 VTE 再住院的危险因素,未调整风险比(RR)和调整 RR(aRR)作为效应的衡量指标。VTE 再住院的时间评估为 10 天间隔,最长 90 天。
我们确定了 872122 例 IBD 索引入院患者;其中 1160 例患者因 VTE 再住院。超过 90%的再住院发生在索引入院出院后 60 天内。与 VTE 再住院相关的因素包括既往 VTE、住院时间较长、合并症、索引入院时进行乙状结肠镜或结肠镜检查以及年龄大于 18 岁。其他危险因素包括索引入院时发生艰难梭菌感染(aRR,1.47;95%CI,1.17-1.85)和出院至专业护理机构或中级护理机构(aRR,1.39;95%CI,1.14-1.70)或出院时接受家庭健康服务(aRR,1.65;95%CI,1.41-1.94)。
在因 IBD 住院的患者中,大多数 VTE 再住院发生在出院后 60 天内。VTE 再住院与艰难梭菌感染以及出院至专业护理机构、中级护理机构或接受家庭健康服务相关。需要开展研究评估对出院后长达 2 个月内的 IBD 住院患者延长 VTE 预防治疗的潜在获益,以降低风险。